資源描述:
《沙美特羅替卡松粉吸入劑治療慢性支氣管炎的效果觀察.doc》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在工程資料-天天文庫。
1、沙美特羅替卡松粉吸入劑治療慢性支氣管炎的效果觀察[摘要]目的評(píng)價(jià)沙美特羅替卡松粉吸入劑治療慢性支氣管炎的臨床效果。方法選取2011年3月?2013年7月本院收治的慢性支氣管炎患者97例,隨機(jī)分為兩組,其中觀察組49例在吸氧、止咳平喘、保持呼吸道通暢、抗感染等常規(guī)治療的基礎(chǔ)上加用沙美特羅替卡松粉吸入劑,對(duì)照組48例僅采用慢性支氣管炎常規(guī)治療,2周后觀察并比較兩組患者的臨床療效和血?dú)夥治鼋Y(jié)果。結(jié)果觀察組優(yōu)32例(65.3%),良15例(30.6%),差2例(4.1%),總優(yōu)良數(shù)為47例(95.9%);對(duì)照組優(yōu)13例(27.1%),良例27(56.3%),差8例(16.7%),總優(yōu)
2、良數(shù)為40例(83.3%),觀察組的臨床療效與對(duì)照組比較差異有統(tǒng)計(jì)學(xué)意義(1X0.05);觀察組經(jīng)過治療P&C02為(45.3±5.2)mmHg,Pa02(88.1+7.5)irrniHg,對(duì)照組PaC02為(55?0±6?7)mmHg,卩a02為(71?9±6?8)mmHg,兩組患者血?dú)夥治鼋Y(jié)果比較差異有統(tǒng)計(jì)學(xué)意義(P〈0?05)°結(jié)論沙美特羅替卡松粉吸入劑治療慢性支氣管炎的臨床效果好,能有效提高患者的血氧飽和度,降低血中二氧化碳含量,值得臨床推廣。[關(guān)鍵詞]沙美特羅替卡松粉吸入劑;慢性支氣管炎;療效[中圖分類號(hào)]R562.2:文獻(xiàn)標(biāo)識(shí)碼]A[文章編號(hào)]1674-4721(
3、2014)06(b)-0058-03EffectobservationofsalmeterolinchoateandfluticasonepropionatepowderforinhalationinthetreatmentofchronicbronchitisZHANGXing-minQTAOXiao-guangGeneralPracticeDepartment,CommunityHealthServiceCentreinKaixuanStreetofJiangganDistrict,IlanzhouCity,Hangzhou310019,China[Abstract]Ob
4、jectiveToevaluatetheclinicaleffectofsalineterolinchoateandfluticasonepropionatepowderforinhalationinthetreatmentofchronicbronchitis?MethodsNinety-sevenpatientswithchronicbronchitisadmittedintoourhospitalfromMarch2011toJuly2013wererandomlydividedintoobservationgroupandcontrolgroup.Intheobser
5、vationgroup(n=49),onthebasisofconventionaltherapyincludingoxygeninhalation,coughandasthmarelieving,respiratorytractkeepingunobstructed,andanti-inflaniniation,salmeterolinchoateandfluticasonepropionatepowderforinhalationwasadded?Inthecontrolgroup(n=48),onlyconventionaltherapywasadopted.After
6、2-weekobservation,theclinicaleffectandoutcomesofbloodgasanalysiswerecomparedinbothgroups?ResultsTheclinicaleffectintheobservationgroupevaluatedasexcellent,goodandpoorwere32cases(65.3%),15cases(30.6%),and2cases(4.1%).Thenumberoftotalexcellentandgoodwere47casesaccountingfor95.9%.Inthecontrolg
7、roup,thenumberofexcellent,goodandpoorwere13cases(27.1%),27cases(56.3%),and8cases(16.7%)respectively.Therewere40casesintotaiwithexcellentandgoodeffectaccountingfor83.3%.Aftercomparisoninthetwogroups,theclinicaleffectdisplayedastatisticaldifference(P<0.05)